A multiomics disease progression signature of low-risk ccRCC

A multiomics disease progression signature of low-risk ccRCC

Abstract Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of adult ccRCC patients (n = 443), we selected low-risk tumors progressing...

Full description

Bibliographic Details
Main Authors: Philipp Strauss, Mariell Rivedal, Andreas Scherer, Øystein Eikrem, Sigrid Nakken, Christian Beisland, Leif Bostad, Arnar Flatberg, Eleni Skandalou, Vidar Beisvåg, Jessica Furriol, Hans-Peter Marti
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-17755-2

Internet

https://doi.org/10.1038/s41598-022-17755-2

Similar Items